Effects of structured hospital‐based care compared with standard care for Type 2 diabetes—The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial

Abstract

This study shows that 2 years of structured care combining lifestyle and pharmacological interventions improved several CV risk factors and reduced the estimated 10-year absolute risk for CHD in patients with Type 2 diabetes.